As of Mar 24
| -0.40 / -1.00%|
The 6 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 80.00, with a high estimate of 89.00 and a low estimate of 17.00. The median estimate represents a +101.51% increase from the last price of 39.70.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.